MedTrace Logo

Blood and Plasma Collection For Use in Future Clinical Trials

NCT01136057 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21

Last updated 2019-03-13

No results posted yet for this study

Summary

Treatment options are limited for the treatment of influenza. This study will collect blood from people who have been exposed to the influenza virus or who have received a seasonal influenza vaccine. The blood plasma will be used in a future clinical trial to treat people hospitalized with influenza.

Conditions

  • Influenza A Virus Infection

Interventions

BIOLOGICAL

Collection of Anti-Influenza A Immune Plasma

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Principal Investigators

  • LCDR Nicholas Martin, USN, MSC · Virology and Rickettsial Diseases Department, Naval Medical Research Center

Eligibility

Min Age
18 Years
Max Age
59 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2019-01-04
Completion
2019-01-04

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01136057 on ClinicalTrials.gov